Zomedica Corp. (AMEX: ZOM) has revealed today the date of the marketing of TRUFORMA™. The drug manufacturer disclosed that it is planning to commence the launch of the TRUFORMA™ point-of-care diagnostic platform on March 30, 2021. From the last few months, the company has